Holter monitoring is a continuous test to record your heart’s rate and rhythm for 24 hours and up to 7 days.

It is necessary when there is a suspected disease but the electrocardiogram doesn’t provide doctors enough information about your heart’s condition.

10) Segmental diskinesia in Wolff-Parkinson-White syndrome: a possible cause of dilatative cardiomiopathy
G Fazio, M Mongiovi’, L Sutera, G. Novo, S Novo, S Pipitone
Int J Cardiol. 2007 Feb 9; [Epub ahead of print] (IF 2,878)

12) A succefully novel ICD implantation and medicalk treatment in a child with LQT syndrome and self-limiting ventricular fibrillation
F Drago, G Fazio, M S Silvetti, G Oricchio, G Michelon
Int J Cardiol. 2007; 118: 108-12 (IF 2,878)

14) SupraVentricular arrhythmias in non-compaction of left ventricle: is this a frequent complication?
G.Fazio, G.Corrado, C. Pizzuto, E.Zachara, C. Rapezzi, AK Sulafa, L.Sutera, C Stollberger, L.Sormani, J Finsterer, A. Benatar, G.Di Gesaro, G. Novo, M Baumhake , F.Vernuccio, F Drago, S. Carerj S.Pipitone, S.Novo
Int J Cardiol. 2007; [Epub ahead of print] (IF 2,878)

16) Chronic pharmacological treatment of the patients affected by Tako-tsubo cardiomyopathy: results from a multicenter international study
G Fazio, G Barbaro, L Sutera, E Incalcaterra, D Guttilla, G Evola, C Pizzuto, S Azzarelli, G Di Gesaro, Y J.Akashi, S Novo
Int J Cardiol. 2007; [Epub ahead of print] (IF 2,878)

20) The total absence of atrial automaticity in a child with sinus node dysfunction.
Drago F, Fazio G, Di Pino A, Silvetti MS.
Nat Clin Pract Cardiovasc Med. 2007;4(9):513-7. (IF 4,743)

21) Pacemaker implantation in children: is this a therapy or a pathogenetic mechanism for ventricular dysfunction?
G Fazio, M S Silvetti, F Drago
G Ital Cardiol . 2007; 7: 612-7

26) Inefficiency of renin-angiotensin inhibitors to prevent the Atrial Fibrillation in patient with normal heart
G Fazio, C Pizzuto, D Guttilla, G Evola, G Di Gesaro, C Cascio, L Sutera, S Novo.
Minerva Cardioangiol. 2007;55:311-5

31) Left ventricular non-compaction cardiomyopathy in children: Is segmental fibrosis the cause of tissue Doppler alterations and of EF reduction?
Fazio G, Novo G, Casalicchio C, Di Gesaro G, Sutera L, Grassedonio E, Cracolici E, Pitruzzella V, Incalcaterra E, Pipitone S, Midiri M, Novo S..
Int J Cardiol. 2007; [Epub ahead of print] (IF 2,878)

32) Successful Radiofrequency Current Ablation of atrial tachycardias in surgically repaired Ebstein’s anomaly using the Carto™ XP System and the QwikStarTM Catheter.
F Drago., G Brancaccio, G Grutter, A De Santis G Fazio, M S Silvetti
J Cardiovasc Med (Hagerstown). 2007; 8: 459-462. (IF 0,756)

35) Transcatheter ablation of supraventricular tachycardias in pediatric patients.
De Santis A, Fazio G, Silvetti MS, Drago F.
Curr Pharm Des. 2008;14:788-93. (IF 4,399)

36) Pharmacological therapy in children with atrial fibrillation and atrial flutter.
Fazio G, Visconti C, D’Angelo L, Novo G, Barbaro G, Novo S.
Curr Pharm Des. 2008;14:770-5. (IF 4,399)

37) Paroxysmal reciprocating supraventricular tachycardia in infants: electrophysiologically guided medical treatment and long-term evolution of the
re-entry circuit
Drago F, Silvetti MS, De Santis A, Marcora S, Fazio G, Anaclerio S, Versacci P, Iodice F, Di Ciommo V.
Europace. 2008 Apr 2 [Epub ahead of print] (IF 1,706)

39) The role of the renin-angiotensin system in atrial fibrillation and the therapeutic effects of ACE-Is and ARBS.
Novo G, Guttilla D, Fazio G, Cooper D, Novo S.
Br J Clin Pharmacol. 2008 Sep;66(3):345-51. (IF 3,128)

41) Risk factors, atrial fibrillation and thromboembolic events.
Novo G, Mansueto P, La Franca ML, Di Leo R, Di Rosa S, Fazio G, Mansueto S, Ferrara F, Novo S.
Int Angiol. 2008 Oct;27(5):433-8. (IF 0.878)
47) Sympathetic tone and ventricular tachycardia.
Fazio G, Novo G, Sutera L, Di Gesaro G, Fazio M, D’angelo L, Visconti C, Vernuccio D, Pipitone S, Novo S.
J Cardiovasc Med (Hagerstown). 2008 Sep;9(9):963-966. (IF 0,756)

49) Post-myocarditis autonomic imbalance: a possible cause of arrhythmias?
Fazio G, Novo G, Sutera L, Amoroso G, Di Gesaro G, D’Angelo L, Visconti C, Pitruzzella V, Novo S.
Minerva Cardioangiol. 2008;56(1):178-80

51) Right lobar pulmonitis: a possible cause of lone atrial fibrillation.
Fazio G, Pipitone S, Garaffa D, Sutera L, D’Angelo L, Lombardi R, Hayes M, Novo G, Novo S.
Minerva Cardioangiol. 2008;56(3):378-379

52) The long QT syndrome in pediatric age: prognosis and risk factor
Fazio G, Pipitone S, D’Angelo L, Di Gesaro G, Sutera L, Visconti G, Evola G, Novo G, Novo S.
Minerva Cardioangiol. 2008; 56(4):387-90.

53) Growth hormone deficiency and increased coronary risk
Novo G, Visconti C, Ciaramitaro GF, Farinella M, Rotolo A, Fazio G, Marturana I, Caruso M, Hoffmann E, Novo S, Assennato P.
Minerva Cardioangiol. 2008; 56(4):442-4

54) Ventricular arrhythmias in children: the uselessness of MRI.
Fazio G, Grassedonio E, Cracolici E, Mongiovi M, Novo G, Sutera L, D’Angelo L, Visconti C, Spoto S, Pipitone S, Ferrara F, Midiri M, Novo S.
Minerva Cardioangiol. 2008 Oct;56(5):575-6.

56) An uncommon case of syncope in a 4-year-old child affected by a long QT syndrome.
Fazio G, D’Angelo L, Gennaro F, Sutera L, Di Gesaro G, Visconti C, Licata P, Rizzo M, Evola G, Ferrara F, Indovina G, Novo G, Novo S.
Minerva Cardioangiol. 2008;56(6):706-7.

64) Syncope in pediatric patients: role of arrhythmias.
Fazio G, Novo G, D’angelo L, Visconti C, Gennaro F, Rizzo M, Sutera L, Lombardi R, Lo Cascio L, Pipitone S, Novo S.
Minerva Cardioangiol. 2009 Apr;57(2):271-2.

67) Ivabradina in paziente con Cardiopatia cronica e test da sforzo positivo
G.Fazio, G.Di Gesaro, l.D’angelo, C.Visconti, P. Licata, S. Passantino, L.Sutera, G.Novo, S. Novo
Gestione della Cardiopatia Ischemica Stabile. Vol Unico. Centro Scientifico Editore

69) Wolff-Parkinson-White syndrome associated with Brugada syndrome.
Fazio G, Augugliaro S, Lunetta M, D’Angelo L, Visconti C, Di Gesaro G, Di Maio C, Novo G, Indovina G, Novo S.
Minerva Cardioangiol. 2009 Jun;57(3):361-4

74) Ivabradine versus bisoprolol.
Fazio G, Sarulo F, Licata P, D’Angelo L, Passantino S, Visconti C, Zarcone P, Spanò C, Novo G, Novo S.
Minerva Cardioangiol. 2010 Apr;58(2):281-2.

87) Heart rate turbulence for guiding electric therapy in patients with cardiac failure.
Fazio G, Sarullo FM, D’Angelo L, Lunetta M, Visconti C, Di Gesaro G, Sutera L, Novo G, Novo S.
J Clin Monit Comput. 2010 Jan 16. [Epub ahead of print] (IF 1,121)

98) News in Therapy of Cardiomiopaty.
Fazio G, Novo S.
Curr Pharm Des. 2010 Jul 15 (IF 4,399)

110) Role of bisoprolol in patients with long QT syndrome.
Fazio G, Vernuccio F, Lo Re G, Grutta G, Mongiovì M.
Ann Noninvasive Electrocardiol. 2013 Sep;18(5):467-70. (IF 1,141)

111) Drugs to be avoided in patients with long QT syndrome: Focus on the anaesthesiological management.
Fazio G, Vernuccio F, Grutta G, Re GL.
World J Cardiol. 2013 Apr 26;5(4):87-93.

114) Sudden cardiac death in athletes: is it always not preventable?.
Vernuccio F, Grutta G, Fazio G.
Recenti Prog Med. 2014 Nov;105(11):410-4

115) Safety of Edoxaban 30 mg in Elderly Patients with Severe Renal Impairment.
Fazio G, Dentamaro I, Gambacurta R, Alcamo P, Colonna P.
Clin Drug Investig. 2018 Nov;38(11):1023-1030. (IF 1,431)